STAR

Strides Pharma Science Share Price Strides Pharma Science

₹839.9
-0.1 (-0.01%)
  • Advice
  • Hold
13 April, 2024 04:34 BSE: 532531 NSE: STARISIN: INE939A01011

Start SIP in Strides Pharma Science

Start SIP

Strides Pharma Science Performance

Day Range

  • Low 837
  • High 848
₹ 839

52 Week Range

  • Low 306
  • High 865
₹ 839
  • Open Price840
  • Previous Close840
  • Volume143449

Strides Pharma Science Share Price

  • Over 1 Month 4.34%
  • Over 3 Month 24.29%
  • Over 6 Month 63.04%
  • Over 1 Year 167.06%

Strides Pharma Science Key Statistics

P/E Ratio -78.5
PEG Ratio -2
Market Cap Cr 7,719
Price to Book Ratio 3.6
EPS 2.3
Dividend 0.2
Relative Strength Index 61.93
Money Flow Index 86.07
MACD Signal 13.98
Average True Range 28.12
Strides Pharma Science Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 520540475564
Operating Expenses Qtr Cr 454497420444
Operating Profit Qtr Cr 664356119
Depreciation Qtr Cr 21212123
Interest Qtr Cr 44403743
Tax Qtr Cr 1313
Net Profit Qtr Cr 31862
IndicatorMar 2023
Total Revenue Annual Cr 1,939
Operating Expenses Annual Cr 1,756
Operating Profit Annual in Cr 98
Depreciation Cr 94
Interest Annual Cr 139
Tax Annual Cr -69
Net Profit Annual Cr 5
IndicatorMar 2023
Cash from Operating Activity Annual Cr 242
Cash from Investing Activity Annual Cr -183
Cash from Financing Annual Activity Cr 11
Net Cash Flow Annual Cr 70
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 3,455
Fixed Assets Annual Cr 652
Total Non Current Assets Annual Cr 3,493
Total Current Assets Annual Cr 2,126
Total Assets Annual Cr 5,620
IndicatorMar 2023
Book Value Per Share Annual Rs 383
ROE Annual % 0
ROCE Annual % 2
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 10
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 1,038999930986
Operating Expenses Qtr Cr 844846763831
Operating Profit Qtr Cr 194153167156
Depreciation Qtr Cr 51606061
Interest Qtr Cr 79797681
Tax Qtr Cr 10-7107
Net Profit Qtr Cr 50-131-7-10
IndicatorMar 2023
Total Revenue Annual Cr 3,779
Operating Expenses Annual Cr 3,258
Operating Profit Annual in Cr 430
Depreciation Cr 243
Interest Annual Cr 261
Tax Annual Cr -55
Net Profit Annual Cr -203
IndicatorMar 2023
Cash from Operating Activity Annual Cr 44
Cash from Investing Activity Annual Cr 302
Cash from Financing Annual Activity Cr -214
Net Cash Flow Annual Cr 133
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 2,195
Fixed Assets Annual Cr 1,948
Total Non Current Assets Annual Cr 3,395
Total Current Assets Annual Cr 3,243
Total Assets Annual Cr 6,638
IndicatorMar 2023
Book Value Per Share Annual Rs 239
ROE Annual % -9
ROCE Annual % 8
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 14

Strides Pharma Science Technicals

EMA & SMA

Current Price
₹839.9
-0.1 (-0.01%)
pointer
  • Bullish Moving Average
  • ___
  • 15
  • Bearish Moving Average
  • ___
  • 1
  • 20 Day
  • ₹813.31
  • 50 Day
  • ₹775.87
  • 100 Day
  • ₹709.21
  • 200 Day
  • ₹614.11
  • 20 Day
  • ₹801.65
  • 50 Day
  • ₹786.23
  • 100 Day
  • ₹694.86
  • 200 Day
  • ₹580.36

Strides Pharma Science Resistance and Support

PIVOT
₹841.64
Resistance
First Resistance 846.27
Second Resistance 852.63
Third Resistance 857.27
RSI 61.93
MFI 86.07
MACD Single Line 13.98
MACD 17.77
Support
First Resistance 835.27
Second Resistance 830.63
Third Resistance 824.27

Strides Pharma Science Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 152,028 8,934,686 58.77
Week 340,919 23,230,187 68.14
1 Month 319,371 16,859,609 52.79
6 Month 763,566 33,306,747 43.62

Strides Pharma Science Result Highlights

Strides Pharma Science Synopsis

NSE-Medical-Generic Drugs

Strides Pharma Scien is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1854.50 Cr. and Equity Capital is Rs. 90.30 Cr. for the Year ended 31/03/2023. Strides Pharma Science Ltd. is a Public Limited Listed company incorporated on 28/06/1990 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1990PLC057062 and registration number is 057062.
Market Cap 7,719
Sales 2,099
Shares in Float 6.71
No of funds 130
Yield 0.18
Book Value 2.2
U/D Vol ratio 2.4
LTDebt / Equity 8
Alpha 0.27
Beta 1.21

Strides Pharma Science

Owner NameDec-23Sep-23Jun-23
Promoters 27.39%27.78%28.07%
Mutual Funds 13.09%13.67%13.86%
Insurance Companies 4.46%4.54%4.54%
Foreign Portfolio Investors 19.45%17.25%16.72%
Financial Institutions/ Banks 0.01%0.01%0.01%
Individual Investors 22.64%23.39%24.93%
Others 12.96%13.36%11.87%

Strides Pharma Science Management

Name Designation
Mr. Arun Kumar Exe.Chairman & Mng.Director
Mr. Badree Komandur Executive Director & Group CFO
Dr. Kausalya Santhanam Independent Director
Mr. Bharat D Shah Independent Director
Mr. Homi Rustam Khusrokhan Independent Director
Mr. S Sridhar Independent Director

Strides Pharma Science Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Strides Pharma Science Corporate Action

Date Purpose Remarks
2024-01-30 Quarterly Results
2023-10-30 Quarterly Results
2023-09-25 Scheme of Arrangement
2023-08-02 Quarterly Results
2023-05-25 Audited Results & Final Dividend
Date Purpose Remarks
2023-08-04 FINAL Rs.1.50 per share(15%)Final Dividend
2021-08-06 FINAL Rs.2.50 per share(25%)Final Dividend

Strides Pharma Science FAQs

What is Share Price of Strides Pharma Science ?

Strides Pharma Science share price is ₹839 As on 13 April, 2024 | 04:20

What is the Market Cap of Strides Pharma Science ?

The Market Cap of Strides Pharma Science is ₹7718.7 Cr As on 13 April, 2024 | 04:20

What is the P/E ratio of Strides Pharma Science ?

The P/E ratio of Strides Pharma Science is -78.5 As on 13 April, 2024 | 04:20

What is the PB ratio of Strides Pharma Science ?

The PB ratio of Strides Pharma Science is 3.6 As on 13 April, 2024 | 04:20

Q2FY23